The Silicon Valley-based health-tech startup RISA Labs, founded by an IIT Kanpur alumnus, has raised $3.5 million in its initial fundraising round to advance its mission of eliminating prior authorization barriers that cause cancer treatment delays.

Binny Bansal, co-founder of Flipkart, led the round, which included participation from Oncology Ventures, General Catalyst, z21 Ventures, ODD BIRD VC, and Ashish Gupta.

The funding will help the business achieve its objective of deploying its main platform, BOSS (Business Operating System as a Service), across 100 cancer centres in the United States within the next two years. BOSS is designed expressly for the complexity of healthcare systems, automating time-consuming administrative operations and substantially reducing treatment delays.

Ben Freeberg, Managing Partner at Oncology Ventures, said, “In oncology, the stakes are higher. Seventy percent of cancer patients experience delays in care because of prior authorization requirements. In 33% of those cases, the delay is one month—a time window that can increase the risk of death by 13% in certain cancer types. The current system isn’t just inefficient – it’s dangerous.”

BOSS breaks down complex operations into smaller, more manageable tasks that are subsequently carried out by a digital workforce made up of reinforcement learning agents, digital twins, and large language models (LLMs).  

The platform integrates AI deeply into operations rather than adding it on top of pre-existing technologies, allowing a 1,000-person business to operate with the productivity of a 2,000-person one overnight.

Kshitij Jaggi, RISA Labs co-founder and CEO, said, “At a time when we’re drowning in software and the labor to operate it is stretched thin, BOSS is an AI operating system designed for the post-ChatGPT era—where work is no longer about learning tools, but expressing intent.”

At one cancer hospital in the United States, BOSS cut prior permission waits from 30 minutes to less than five, processed over $1 million in medication, and freed up 80% of administrative staff work, resulting in a 66% cost reduction.

RISA Labs was founded in 2024 by Jaggi and CTO Kumar Shivang, who had previously developed Urban Health. The founders were frustrated with the fragmented, high-friction workflows they observed in the healthcare system.  Their approach was to create not just a smarter tool, but an AI system capable of comprehending and coordinating institutional procedures from start to finish.

RISA aims to become the AI orchestration layer for the entire cancer care ecosystem by expanding into a range of oncology touchpoints in the future, including providers, life sciences firms, and care coordination platforms.

Tired of guessing stocks to trade in daily?
Unicorn Signals empowers you with powerful tools like daily stock scans for Intraday, Swing & Investing, Market Predictions and much more. Download the Unicorn Signals app today and take control of your investments!